Published in BMC Infect Dis on April 15, 2014
How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World? Clin Infect Dis (2016) 1.63
Adherence influencing factors - a systematic review of systematic reviews. Arch Public Health (2014) 0.93
The Australasian Hepatology Association consensus guidelines for the provision of adherence support to patients with hepatitis C on direct acting antivirals. Patient Prefer Adherence (2016) 0.93
High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study. Hepatol Int (2015) 0.84
The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free era. Can J Gastroenterol Hepatol (2014) 0.82
Recent advances in management of the HIV/HCV coinfected patient. Future Virol (2016) 0.81
Rational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus Infection. PLoS Comput Biol (2015) 0.77
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment. Can J Infect Dis Med Microbiol (2016) 0.75
A multidimensional education program at substance dependence treatment centers improves patient knowledge and hepatitis C care. BMC Infect Dis (2016) 0.75
Financial Incentives for Adherence to Hepatitis C Virus Clinical Care and Treatment: A Randomized Trial of Two Strategies. Open Forum Infect Dis (2017) 0.75
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (2013) 12.46
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. N Engl J Med (2009) 10.21
Medication compliance and persistence: terminology and definitions. Value Health (2008) 7.58
Language bias in randomised controlled trials published in English and German. Lancet (1997) 7.29
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol (2010) 4.43
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology (2004) 4.27
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr (2001) 3.83
A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol (2012) 3.72
Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology (2010) 2.64
The impact of patient participation on adherence and clinical outcome in primary care of depression. Patient Educ Couns (2007) 2.05
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology (2003) 1.86
Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol (2009) 1.84
Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med (2011) 1.75
Intentional and unintentional nonadherence: a study of decision making. J Behav Med (2002) 1.73
Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study. Liver Int (2011) 1.64
Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence. Liver Transpl (2007) 1.61
Systematic reviews of low back pain prognosis had variable methods and results: guidance for future prognosis reviews. J Clin Epidemiol (2009) 1.57
Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud (2006) 1.49
Adherence to hepatitis C treatment in recovering heroin users maintained on methadone. Eur J Gastroenterol Hepatol (2007) 1.42
A systematic review of adherence to cardiovascular medications in resource-limited settings. J Gen Intern Med (2011) 1.33
An evidence-based review of treatment-related determinants of patients' nonadherence to HIV medications. AIDS Patient Care STDS (2009) 1.27
Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study. Ann Intern Med (2011) 1.17
Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treat Rev (2013) 1.15
The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysis. PLoS One (2013) 1.13
De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C. Aliment Pharmacol Ther (2007) 0.96
Categorizing continuous variables resulted in different predictors in a prognostic model for nonspecific neck pain. J Clin Epidemiol (2009) 0.92
Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence. J Viral Hepat (2013) 0.88
Evaluation of medication adherence and quality of life in patients with hepatitis C virus receiving combination therapy. Gastroenterol Nurs (2010) 0.87
Poor response to hepatitis C virus (HCV) therapy in HIV- and HCV-coinfected patients is not due to lower adherence to treatment. AIDS Res Hum Retroviruses (2006) 0.85
Does depression symptomatology affect medication compliance during the first weeks of anti-HCV therapy in intravenous drug users? Dig Liver Dis (2005) 0.84
Factors associated with adherence to combination therapy of interferon and ribavirin for patients with chronic hepatitis C: importance of patient's motivation and physician's treatment experience. Liver Int (2009) 0.82
Interventions for enhancing medication compliance/adherence with benefits in treatment outcomes. GMS Health Technol Assess (2008) 0.82
Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone. AIDS Care (2006) 0.81
Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients. AIDS Behav (2013) 0.80
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients. Transpl Int (2012) 0.80
Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients. AIDS Res Treat (2011) 0.80
Methods of international health technology assessment agencies for economic evaluations--a comparative analysis. BMC Health Serv Res (2013) 1.09
Commentary: Europe needs a central, transparent, and evidence based regulation process for devices. BMJ (2013) 1.06
Adherence enhancing interventions for oral anticancer agents: a systematic review. Cancer Treat Rev (2013) 1.00
50% adherence of patients suffering chronic conditions--where is the evidence? Ger Med Sci (2012) 0.84
Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials. BMC Endocr Disord (2014) 0.83
Cost-effectiveness of adherence interventions for highly active antiretroviral therapy: a systematic review. Int J Technol Assess Health Care (2013) 0.78
[Overviews - status quo, potentials and perspectives]. Z Evid Fortbild Qual Gesundhwes (2013) 0.76
HEALTH TECHNOLOGY ASSESSMENT OF PUBLIC HEALTH INTERVENTIONS: A SYNTHESIS OF METHODOLOGICAL GUIDANCE. Int J Technol Assess Health Care (2017) 0.75
[In Process Citation]. Zentralbl Chir (2015) 0.75